Armor Investment Advisors LLC lowered its position in shares of Healthpeak Properties, Inc. (NYSE:DOC - Free Report) by 31.2% in the 1st quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 32,076 shares of the real estate investment trust's stock after selling 14,543 shares during the period. Armor Investment Advisors LLC's holdings in Healthpeak Properties were worth $649,000 as of its most recent filing with the Securities & Exchange Commission.
Several other institutional investors and hedge funds also recently made changes to their positions in the company. Commerzbank Aktiengesellschaft FI boosted its holdings in Healthpeak Properties by 15.3% in the first quarter. Commerzbank Aktiengesellschaft FI now owns 24,219 shares of the real estate investment trust's stock worth $490,000 after purchasing an additional 3,217 shares during the last quarter. Verdence Capital Advisors LLC boosted its holdings in Healthpeak Properties by 52.2% in the first quarter. Verdence Capital Advisors LLC now owns 27,035 shares of the real estate investment trust's stock worth $547,000 after purchasing an additional 9,277 shares during the last quarter. Tectonic Advisors LLC boosted its holdings in Healthpeak Properties by 10.0% in the first quarter. Tectonic Advisors LLC now owns 405,188 shares of the real estate investment trust's stock worth $8,193,000 after purchasing an additional 36,794 shares during the last quarter. Larson Financial Group LLC boosted its holdings in Healthpeak Properties by 120.6% in the first quarter. Larson Financial Group LLC now owns 1,873 shares of the real estate investment trust's stock worth $38,000 after purchasing an additional 1,024 shares during the last quarter. Finally, Wealthfront Advisers LLC boosted its holdings in Healthpeak Properties by 3.9% in the first quarter. Wealthfront Advisers LLC now owns 281,295 shares of the real estate investment trust's stock worth $5,688,000 after purchasing an additional 10,542 shares during the last quarter. Institutional investors own 93.57% of the company's stock.
Insiders Place Their Bets
In other Healthpeak Properties news, Director Tommy G. Thompson purchased 5,777 shares of the stock in a transaction dated Wednesday, May 28th. The stock was purchased at an average price of $17.27 per share, with a total value of $99,768.79. Following the transaction, the director owned 144,290 shares of the company's stock, valued at approximately $2,491,888.30. This trade represents a 4.17% increase in their ownership of the stock. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, Director John T. Thomas purchased 4,200 shares of the stock in a transaction dated Monday, April 28th. The stock was acquired at an average cost of $17.84 per share, with a total value of $74,928.00. Following the transaction, the director directly owned 813,566 shares in the company, valued at approximately $14,514,017.44. This trade represents a 0.52% increase in their position. The disclosure for this purchase can be found here. Insiders have purchased 29,764 shares of company stock worth $521,909 in the last three months. Corporate insiders own 0.23% of the company's stock.
Healthpeak Properties Price Performance
Shares of Healthpeak Properties stock traded down $0.03 during trading hours on Friday, reaching $18.33. The company's stock had a trading volume of 4,445,200 shares, compared to its average volume of 5,384,662. Healthpeak Properties, Inc. has a one year low of $16.64 and a one year high of $23.26. The company has a debt-to-equity ratio of 1.01, a current ratio of 1.35 and a quick ratio of 1.35. The firm has a 50 day moving average price of $17.56 and a 200-day moving average price of $18.89. The stock has a market cap of $12.73 billion, a P/E ratio of 45.83, a P/E/G ratio of 2.09 and a beta of 1.03.
Healthpeak Properties (NYSE:DOC - Get Free Report) last released its quarterly earnings results on Thursday, April 24th. The real estate investment trust reported $0.46 EPS for the quarter, hitting analysts' consensus estimates of $0.46. Healthpeak Properties had a net margin of 9.99% and a return on equity of 3.06%. The firm had revenue of $702.89 million during the quarter, compared to analysts' expectations of $690.76 million. During the same period in the previous year, the company earned $0.45 EPS. The firm's revenue for the quarter was up 15.9% compared to the same quarter last year. On average, analysts predict that Healthpeak Properties, Inc. will post 1.86 EPS for the current year.
Healthpeak Properties Dividend Announcement
The business also recently announced a monthly dividend, which will be paid on Tuesday, September 30th. Shareholders of record on Friday, September 19th will be paid a $0.1017 dividend. The ex-dividend date is Friday, September 19th. This represents a $1.22 dividend on an annualized basis and a yield of 6.66%. Healthpeak Properties's dividend payout ratio is currently 305.00%.
Wall Street Analyst Weigh In
Several brokerages have recently weighed in on DOC. Wells Fargo & Company dropped their price target on shares of Healthpeak Properties from $22.00 to $20.00 and set an "equal weight" rating on the stock in a research note on Monday, June 2nd. Robert W. Baird dropped their price target on shares of Healthpeak Properties from $24.00 to $22.00 and set an "outperform" rating on the stock in a research note on Tuesday, April 29th. Wedbush dropped their price target on shares of Healthpeak Properties from $24.00 to $22.00 and set an "outperform" rating on the stock in a research note on Monday, April 28th. Wall Street Zen cut shares of Healthpeak Properties from a "hold" rating to a "sell" rating in a research note on Monday, July 7th. Finally, Argus reiterated a "buy" rating and set a $25.00 price target on shares of Healthpeak Properties in a research note on Tuesday, April 29th. One investment analyst has rated the stock with a sell rating, two have issued a hold rating and nine have issued a buy rating to the company's stock. According to data from MarketBeat.com, Healthpeak Properties has a consensus rating of "Moderate Buy" and an average target price of $23.27.
Read Our Latest Analysis on DOC
Healthpeak Properties Profile
(
Free Report)
Healthpeak Properties, Inc is a fully integrated real estate investment trust (REIT) and S&P 500 company. Healthpeak owns, operates, and develops high-quality real estate for healthcare discovery and delivery.
Featured Stories

Before you consider Healthpeak Properties, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Healthpeak Properties wasn't on the list.
While Healthpeak Properties currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.